Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Company News
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Events
Directory
Editorial team
Search
Close search
Subscribe
Login
Password
Password
Remember me
Forgot password?
Close login form
Home
Company News
Company News
New management team at Evolva to deliver strategic priorities
New management team at Evolva to deliver strategic priorities
Former Lonza CEO has been proposed to join the Swiss biotech and ingredients company
PhoreMost fills Director roles with an OBE and a PhD
PhoreMost fills Director roles with an OBE and a PhD
UK biopharma has appointed Dr Beech as a Non-Executive Director and Dr Cross as Senior Director of Technology
Clasado CEO Per Rehné joins Global Prebiotic Association’s Communications Committee
Clasado CEO Per Rehné joins Global Prebiotic Association’s Communications Committee
Rehné will work to establish a proactive, objective voice on issues of importance to the prebiotic community
Matthew Durdy to spearhead CGT Catapult
Matthew Durdy to spearhead CGT Catapult
Durdy will take up the role of Chief Executive Officer in April this year
ACG Group names new Chief Marketing Officer
ACG Group names new Chief Marketing Officer
Alexander Robinson has been chosen to replace Peter Neve at Head office in Mumbai, as his predecessor returns to his home country
FDA swears in Dr Stephen Hahn as new Commissioner
FDA swears in Dr Stephen Hahn as new Commissioner
Oncolgy specilalist Dr Stephen Hahn has started his new position as leader of the US regulatory body
Former Celgene CEO joins board of Chinese-US joint venture
Former Celgene CEO joins board of Chinese-US joint venture
The Antengene board has appointed Mark Alles as an independent director of the company
Avacta Group appoints new Non-Executive Director
Avacta Group appoints new Non-Executive Director
Paul Fry has been appointed to the senior role and will begin in February
Catalent strengthens biologics business with key senior appointments
Catalent strengthens biologics business with key senior appointments
Karen Flynn has been appointed President of Biologics and Chief Commercial Officer alongside two other regional biologic Presidents
Abcam announces new Chief Financial Officer
Abcam announces new Chief Financial Officer
Michael Baldock to take on the role as Gavin Wood will step down on 3 February 2020
Nanoform appoints Head of US Sales
Nanoform appoints Head of US Sales
Clasado boosts product development with key appointment
Clasado boosts product development with key appointment
Dr Lucien Harthoorn has taken the role of Research & Development Director to oversee developments at the prebiotic ingredients company
Chr Hansen and Lonza appoint new CEO for BacThera
Chr Hansen and Lonza appoint new CEO for BacThera
Chr Hansen and Lonza joint venture company focuses on live-biotherapeutics has appointed Lukas Schüpbach as CEO
Cambrex makes changes to management and Board of Directors
Cambrex makes changes to management and Board of Directors
MedPharm appoints Lynn Allen VP of Business Development
MedPharm appoints Lynn Allen VP of Business Development
New Head of Quality Control at Euromed
New Head of Quality Control at Euromed
In his new role as Head of Quality Control at Euromed, Xavier is responsible for quality and process control from the raw materials to the finished products
Previous
1
…
30
31
32
33
(current)
34
35
36
…
214
Next
Trending Articles
Alfa Laval appoints new managing director to drive strategic growth
Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
How strong leadership transforms regulatory and operational challenges
Why SLTs fail on the PQS/QMS: The leadership gap undermining quality
Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors
A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
Kindeva appoints Brok Weichbrodt as Chief Transformation Officer to accelerate growth strategy and commercial excellence
Kindeva, a global drug delivery Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Brok Weichbrodt as Chief Transformation Officer to strengthen operational excellence, scale execution, and accelerate growth as the company enters the next phase of its value creation plan
Medicines Discovery Catapult selects prominent UK life sciences leader, Professor Sir Mike Ferguson, as its incoming Chair of the Board
MDC welcomes new Chair from January 2027 to drive impact as next-generation technologies and collaborations reshape drug discovery
Upcoming event
CPhI Milan
6–8 October 2026 | Exhibition | Fiera Milano, Italy
See all